Comparison of MRI artificial intelligence-guided cognitive fusion-targeted biopsy versus routine cognitive fusion-targeted prostate biopsy in prostate cancer diagnosis: a randomized controlled trial

Authors

Chaojian Yu (ORCID: https://orcid.org/0000-0001-9913-4073)
Jiwen Shang (ORCID: https://orcid.org/0000-0003-2971-4683)
Jianhui Qiu (ORCID: https://orcid.org/0000-0002-4393-612X)
Jingcheng Zhou (ORCID: https://orcid.org/0000-0002-6226-5667)
Jingyun Wu (ORCID: https://orcid.org/0000-0002-9182-2127)
Mingjian Ruan (ORCID: https://orcid.org/0009-0002-3051-526X)
Kan Gong (ORCID: https://orcid.org/0000-0001-7195-677X)
Ruiyi Deng (ORCID: https://orcid.org/0009-0008-9632-5753)
Pengsheng Wu
Xiaoying Wang (ORCID: https://orcid.org/0000-0001-9822-961X)
Kexin Wang (ORCID: https://orcid.org/0000-0001-9184-3967)
Yi Liu (ORCID: https://orcid.org/0000-0003-0240-0369)
Derun Li (ORCID: https://orcid.org/0000-0003-0512-6684)
Peidong Tian
Zihou Zhao
Lin Cai

Institutions

Capital Medical University (CN)
Peking University (CN)
National Clinical Research Center for Digestive Diseases (CN)
Beijing Chest Hospital (CN)
Peking University First Hospital (CN)

Publication Details

Journal: BMC Medicine
Published: 2024-11-13
DOI: https://doi.org/10.1186/s12916-024-03742-z
Citations: 14
Primary Topic: Prostate Cancer Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 5.87

Funders

Peking University First Hospital
National Natural Science Foundation of China
Peking University

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Comparison of MRI artificial intelligence-guided cognitive fusion-targeted biopsy versus routine cognitive fusion-targeted prostate biopsy in prostate cancer diagnosis: a randomized controlled trial

Chaojian Yu, Jiwen Shang, Jianhui Qiu, Jingcheng Zhou et al.

Nov 13, 2024

14 citations

BMC Medicine

Prostate Cancer Diagnosis and Treatment

5.87

article

Comparison of MRI artificial intelligence-guided cognitive fusion-targeted biopsy versus routine cognitive fusion-targeted prostate biopsy in prostate cancer diagnosis: a randomized controlled trial

Chaojian Yu, Jiwen Shang, Jianhui Qiu, Jingcheng Zhou, Jingyun Wu, Mingjian Ruan, Kan Gong, Ruiyi Deng, Pengsheng Wu, Xiaoying Wang, Kexin Wang, Yi Liu, Derun Li, Peidong Tian, Zihou Zhao, Lin Cai

November 13, 2024article en

14 citations

Abstract

No abstract available for this paper.

BMC MedicineVol. 22(1)

Capital Medical University (CN), Peking University (CN), National Clinical Research Center for Digestive Diseases (CN), Beijing Chest Hospital (CN), Peking University First Hospital (CN)

Peking University First Hospital, National Natural Science Foundation of China, Peking University

Good health and well-being

Openalex Percentile: Top 3%

Prostate Cancer Diagnosis and Treatment

5.87

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comparison of MRI artificial intelligence-guided cognitive fusion-targeted biopsy versus routine cognitive fusion-targeted prostate biopsy in prostate cancer diagnosis: a randomized controlled trial — Chaojian Yu, Jiwen Shang, et al. · BMC Medicine (2024) | TGRS Research Map | TGRS